LIAS Promotes Cuproptosis in Prostate Cancer Cells by Suppressing Glycolysis via the p53 Signaling Pathway
The Prostate · 2026-01 · 86 (1) · 12-19
DOI: 10.1002/pros.70049 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Prostate, 2025-10. Verfasst von Zhe Tang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Affiliated Hospital of Yangtze University, Jingzhou, China. Hauptthemen laut MEDLINE: Glycolysis, Prostatic Neoplasms, Tumor Suppressor Protein p53, Copper. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Background
Cuproptosis holds significant potential for optimizing cancer therapeutic strategies. However, the molecular mechanism by which lipoic acid synthase (LIAS) regulates cuproptosis in prostate cancer (PC) remains unclear.
Methods
The GEPIA online tool and PC cell lines were used to analyze the expression of LIAS in PC. Cuproptosis characteristics were assessed using Cu²⁺ detection kits, Western blot (LIAS/FDX1), and immunofluorescence (DLAT oligomerization). Cell viability and proliferation capacity were determined by CCK‐8 and colony formation assays. qPCR was used to detect p53 pathway gene expression. Glycolytic activity was analyzed by measuring extracellular acidification rate (ECAR), glucose uptake, and ATP levels. The regulatory relationship was validated using glycolytic inhibitors within the cuproptosis model.
Results
LIAS expression was significantly downregulated in both PC and cuproptosis models. Overexpression of LIAS enhanced cuproptosis effects and suppressed the viability and proliferative capacity of cancer cells. Further analysis revealed that LIAS suppressed glycolysis by activating the p53 pathway, manifested by decreased extracellular acidification rate (ECAR), reduced glucose uptake, and diminished ATP levels. Notably, inhibition of glycolysis promoted cuproptosis, thereby impeding tumor progression.
Conclusion
LIAS promotes cuproptosis and inhibits cancer cell proliferation in PC by activating the p53 signaling pathway to suppress glycolytic activity. These findings indicate that LIAS represents a potential therapeutic target for intervening in PC, and regulation of the glycolysis‐cuproptosis axis may serve as an effective strategy for improving PC progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, The First Affiliated Hospital of Yangtze University, Jingzhou, China.
ORCID-Profile: Yuanhua Liu
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Tang, Z., Guo, P., & Liu, Y. (2026). LIAS Promotes Cuproptosis in Prostate Cancer Cells by Suppressing Glycolysis via the p53 Signaling Pathway. The Prostate, 86(1), 12-19. https://doi.org/10.1002/pros.70049
Vancouver
Tang Z, Guo P, Liu Y. LIAS Promotes Cuproptosis in Prostate Cancer Cells by Suppressing Glycolysis via the p53 Signaling Pathway. The Prostate. 2026;86(1):12-19. doi:10.1002/pros.70049
BibTeX
@article{Tang2026,
author = {Tang, Zhe and Guo, Peichao and Liu, Yuanhua},
title = {LIAS Promotes Cuproptosis in Prostate Cancer Cells by Suppressing Glycolysis via the p53 Signaling Pathway},
journal = {The Prostate},
year = {2026},
volume = {86},
number = {1},
pages = {12--19},
doi = {10.1002/pros.70049}
}
EUVIMED